LAG3 Expression in Triple Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Immune Checkpoint Inhibitor
Interventions: PROCEDURE: LAG-3 expression / immune checkpoint protein expression
Sponsor: Samsung Medical Center